HIV & AIDS

NMAC Launches Campaign to Fight Proposed Cuts to HIV Services

Today, NMAC Launches “Save Our Services,” an innovative campaign created to empower Americans across the country in fighting the proposed federal budget cuts that would cause severe harm to vital HIV treatment and prevention services. SOS will enlist the advocacy of community volunteers to contact their representatives in Congress both in their home offices during(…)

FDA Application Accepted for HIV Drug with New Mechanism of Action

Theratechnologies Inc. (Theratechnologies) (TSX: TH) announced Friday that it has been notified by its partner, TaiMed Biologics, Inc., that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for ibalizumab as a treatment for multidrug resistant Human Immunodeficiency Virus-1 (MDR HIV-1). If approved, ibalizumab will be the first(…)

AIDS United Releases Statement for Providing Trans-affirming HIV Medical Care, Support Services and Funding

In a community-created consensus statement released today, AIDS United provides critical guidance for clinical providers, funders and social service providers to strengthen their understanding of how best to engage and support transgender communities. The statement provides concrete and measurable steps organizations can take to improve their approach to HIV work in transgender communities and was(…)

PleasePrEPMe.org seeks to expand access to PrEP within California

  HIVE (hiveonline.org) and Project Inform (projectinform.org) are pleased to announce the hiring of three key positions for supporting PrEP services within California and nationally through expanded navigation services at PleasePrEPMe.org (PPM). The launch date of these free new services is being planned for early April. “HIVE launched PleasePrEPMe.org in 2015 to provide consumers a(…)

Public Health Experts Affirm Virally Suppressed People Living With HIV Do Not Transmit the Virus

Today, NASTAD (National Alliance of State & Territorial AIDS Directors), a leading non-partisan non-profit association that represents public health officials who administer HIV and hepatitis programs in the U.S. and around the world, published a new statement affirming that durably virally suppressed people living with HIV on antiretroviral therapy (ART) do not sexually transmit the virus.(…)

First Large-scale Clinical Study of Long-acting Injectable HIV Drug Begins

The first large-scale clinical trial of a long-acting injectable drug for HIV prevention began today. The study, sponsored by the National Institutes of Health, will examine whether a long-acting form of the investigational anti-HIV drug cabotegravir injected once every 8 weeks can safely protect men and transgender women from HIV infection at least as well(…)

Generic HIV drugs will be a good thing right?

 In 2017, the patents for two antiretroviral drugs for HIV that continue to be widely used will  likely expire in the United States and generic alternatives at lower market prices could be introduced. Some have long awaited this occurrence, hoping for increased competition and a drive to lower prices for all HIV medications. However, it(…)

Sugar-binding Protein Galectin-9 Found to be a New Weapon to Cure HIV

The ultimate impediment to a cure for HIV infection is the presence of latent, HIV-infected cells, which can reawaken and produce new virus when antiretroviral drug therapy is stopped.  These latent, HIV-infected cells are untouched by antiretroviral therapy and are unseen by the immune system.  Moving medicine closer to a cure for HIV, scientists at(…)